Detalhe da pesquisa
1.
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets.
Am J Hematol
; 98(6): E134-E138, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36882876
2.
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe.
Hematol Oncol
; 40(3): 370-380, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35168291
3.
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Am J Hematol
; 90(8): 686-90, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25925613
4.
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Blood
; 130(15): 1772-1774, 2017 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28801448
5.
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Cancer Med
; 12(6): 6536-6546, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36373169
6.
A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients.
Am J Hematol
; 91(6): E305-7, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26950187
7.
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.
Cancer Med
; 6(11): 2507-2514, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28960797
8.
[Economic cost of peripheral blood progenitor cell transplantation in Spain]. / Trasplante de progenitores hematopoyéticos de sangre periférica en España: análisis de coste.
Med Clin (Barc)
; 123(11): 401-5, 2004 Oct 02.
Artigo
Espanhol
| MEDLINE | ID: mdl-15482712
9.
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 1(3): e104-11, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27029228